Loading...
Loading...
Among the 8 tracked institutional investors we monitor, KPTI (KARYOPHARM THERAPEUTICS INC) is held with a combined value of $12.37M across 2,040,410 shares. The largest holder is VANGUARD GROUP INC with a position worth $4.12M (0.00% of their portfolio). 3 funds opened new positions in the most recent quarter. 3 funds increased their holdings. 2 funds reduced their position.
Total Institutional Value
$12.37M
Total Shares Held
2,040,410
Institutional Holders
8
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $4.12M | 0.00% | New |
| 2 | MILLENNIUM MANAGEMENT LLC | $2.85M | 0.00% | New |
| 3 | CITADEL ADVISORS LLC | $2.83M | 0.00% | +274.5% |
| 4 | BlackRock, Inc. | $1.36M | 0.00% | -1.1% |
| 5 | RENAISSANCE TECHNOLOGIES LLC | $587.16K | 0.00% | +75.9% |
| 6 | STATE STREET CORP | $449.73K | 0.00% | +37.0% |
| 7 | Point72 Asset Management, L.P. | $167.10K | 0.00% | New |
| 8 | FMR LLC | $3.70K | 0.00% | -2.1% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of KPTI with a position worth $4.12M, representing 0.00% of their portfolio. In total, 8 institutional investors hold KPTI with a combined value of $12.37M.
In the most recent quarter, 3 funds opened a new position in KPTI. Additionally, 3 increased their holdings and 2 reduced their positions.
Institutional investors hold $12.37M worth of KPTI stock across 8 positions. The largest institutional holder is VANGUARD GROUP INC with $4.12M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For KPTI, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their KPTI positions.